dc.contributor.author | Jingya, Wang | |
dc.contributor.author | Cooper, Jennifer M. | |
dc.contributor.author | Surenthirakumaran, R. | |
dc.date.accessioned | 2023-08-18T03:31:50Z | |
dc.date.available | 2023-08-18T03:31:50Z | |
dc.date.issued | 2021 | |
dc.identifier.citation | The Journal of Clinical Endocrinology & Metabolism, 2021, Vol. 106, No. 5, | en_US |
dc.identifier.uri | http://repo.lib.jfn.ac.lk/ujrr/handle/123456789/9631 | |
dc.language.iso | en | en_US |
dc.publisher | Oxford University Press | en_US |
dc.subject | Type 2 diabetes mellitus | en_US |
dc.subject | Metformin | en_US |
dc.subject | COVID-19 | en_US |
dc.subject | SARS-CoV-2 infection | en_US |
dc.title | Association of Metformin with Susceptibility to COVID-19 in People with Type 2 Diabetes | en_US |
dc.type | Article | en_US |